Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality

Starting soon · Phase 3

Conditions studied: Skin Aging, Facial Aging, Skin Quality

In brief

This study aims to evaluate the potential effects of mesenchymal stem cell-derived suspended exosome therapy on facial skin quality using objective imaging analysis. Forty adult participants will receive intradermal exosome applications in three treatment sessions performed at one-month intervals. Facial skin analysis will be conducted using the VISIA imaging system before each treatment session and six months after the final treatment. The study will examine changes in multiple facial skin characteristics including wrinkles, pigmentation, skin texture, pores, UV spots, red areas, brown spots, and porphyrins to determine whether exosome therapy may improve overall facial skin quality.

Key facts

Study ID
NCT07466953
Run by
Mert Ersan
People needed
40
Starts
2026-07-10
Expected to finish
2026-12-31
Last updated by the study team
2026-08-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.